Search

Search Constraints

You searched for: Author/Creator Sekulic, Aleksandar

Search Results

1. 428 Interim analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (mBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIs). (10th December 2020)

3. Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial. Issue 6 (June 2021)

4. Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma. (10th August 2016)

5. Characterization and Management of Hedgehog Pathway Inhibitor‐Related Adverse Events in Patients With Advanced Basal Cell Carcinoma. (10th August 2016)

6. Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials. Issue 1 (3rd October 2018)

8. Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion. Issue 2 (27th November 2014)

9. Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion. Issue 2 (27th November 2014)